Owing to the ability to chelate calcium, InsP6 has been studied as a
preventive and therapeutic agent for abnormal calcification in various tissues such as
blood vessels in atherosclerosis and skin in calcinosis cutis; kidney and salivary gland
stones; prevention of dental caries and bone loss as in osteoporosis, etc. The results are
very promising for wide-range practical application of InsP6 especially against the
serious debilitating problem of osteoporosis amongst the seniors, globally.
Keywords: Calcinosis cutis, caries, crystallization inhibitor, dystrophic
calcification, fluoride, hydroxyapatite, kidney stone, metastatic calcification,
osteoblast, osteoclast, pyrophosphate, sialolithiasis, titratable acidity, tooth decay.
